AG
AVEO

Advisor Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Advisor Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Sell
338
-783
-70% -$5.76K ﹤0.01% 5068
2019
Q3 		$10K Buy
1,121
+674
+151% +$5.01K ﹤0.01% 4371
2019
Q2 		$3K Buy
447
+100
+29% +$857 ﹤0.01% 4928
2019
Q1 		$3K Hold
347
– – ﹤0.01% 4903
2018
Q4 		$6K Hold
347
– – ﹤0.01% 4476
2018
Q3 		$12K Buy
347
+10
+3% +$257 ﹤0.01% 4212
2018
Q2 		$7K Buy
337
+150
+80% +$3.56K ﹤0.01% 4281
2018
Q1 		$5K Sell
187
-510
-73% -$14.9K ﹤0.01% 4454
2017
Q4 		$20K Buy
697
+100
+17% +$3.1K ﹤0.01% 3733
2017
Q3 		$22K Buy
597
+550
+1,170% +$17K ﹤0.01% 3522
2017
Q2 		$1K Hold
47
– – ﹤0.01% 4727
2017
Q1 		$0 Hold
47
– – ﹤0.01% 4872
2016
Q4 		$0 Hold
47
– – ﹤0.01% 4714
2016
Q3 		$0 Hold
47
– – ﹤0.01% 4699
2016
Q2 		$0 Buy
+47
New +$453 ﹤0.01% 4573

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

Advisor Group's AVEO Position: Q4 2019 in Review

Advisor Group reduced its AVEO Pharmaceuticals, Inc. (AVEO) stake by 70% in Q4 2019, selling an estimated $5.76K and leaving 338 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5068.

Advisor Group first reported a position in AVEO in Q2 2016 and has held it in 15 quarters since. The position peaked at $22K in Q3 2017. 61 funds tracked by Wall St. Rank hold AVEO as of Q4 2019.

  • Advisor Group held 338 shares of AVEO Pharmaceuticals, Inc. worth $2K as of Q4 2019.
  • Advisor Group sold 783 AVEO Pharmaceuticals, Inc. shares in Q4 2019, an estimated $5.76K.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5068 holding.
  • Advisor Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's AVEO Pharmaceuticals, Inc. position peaked at $22K in Q3 2017.
  • 61 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.